Lopressor injection/black box warning: Difference between revisions
Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{{{BASEPAGENAME}} }} {{CMG}} {| style="border: 3px solid #696969;" | style="background: #000000; border: 0px; padding: 20px 20px; width: 800px;" | <center> <font c...") |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 6: | Line 6: | ||
| style="background: #000000; border: 0px; padding: 20px 20px; width: 800px;" | | | style="background: #000000; border: 0px; padding: 20px 20px; width: 800px;" | | ||
<center> | <center> | ||
<font color="#F8F8FF"> | <font color="#F8F8FF" style="font-weight: bold;">WARNING</font> | ||
</center> | </center> | ||
<center> | <center> | ||
<font color="#F8F8FF" size="1"> | <font color="#F8F8FF" size="1" style="font-style: italic;">See full prescribing information for complete boxed warning.</font> | ||
</center> | </center> | ||
<font color="#F8F8FF" style="font-weight: bold;"> | |||
''[[Ischemic heart disease|{{fontcolor|#FF0000|Ischemic Heart Disease}}]]'': Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred. When discontinuing chronically administered Lopressor, particularly in patients with ischemic heart disease, the dosage should be gradually reduced over a period of 1-2 weeks and the patient should be carefully monitored. If angina markedly worsens or acute coronary insufficiency develops, Lopressor administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken. Patients should be warned against interruption or discontinuation of therapy without the physician’s advice. Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue Lopressor therapy abruptly even in patients treated only for hypertension.</font> | ''[[Ischemic heart disease|{{fontcolor|#FF0000|Ischemic Heart Disease}}]]'': Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred. When discontinuing chronically administered Lopressor, particularly in patients with ischemic heart disease, the dosage should be gradually reduced over a period of 1-2 weeks and the patient should be carefully monitored. If angina markedly worsens or acute coronary insufficiency develops, Lopressor administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken. Patients should be warned against interruption or discontinuation of therapy without the physician’s advice. Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue Lopressor therapy abruptly even in patients treated only for hypertension. | ||
|} | </font>|} | ||
Revision as of 01:53, 21 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
WARNING See full prescribing information for complete boxed warning. Ischemic Heart Disease: Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred. When discontinuing chronically administered Lopressor, particularly in patients with ischemic heart disease, the dosage should be gradually reduced over a period of 1-2 weeks and the patient should be carefully monitored. If angina markedly worsens or acute coronary insufficiency develops, Lopressor administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken. Patients should be warned against interruption or discontinuation of therapy without the physician’s advice. Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue Lopressor therapy abruptly even in patients treated only for hypertension. |} |